Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
$0.77
-2.4%
$1.12
$0.74
$1.76
$30.51M1.09663,555 shs176,794 shs
AECOM stock logo
ACM
AECOM
$93.72
-0.3%
$93.05
$74.40
$98.72
$12.75B1.24727,511 shs177,899 shs
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
$5.96
-0.2%
$6.00
$3.50
$7.40
$29.09M0.013,233 shs1,016 shs
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
$6.40
+2.1%
$6.79
$3.71
$8.23
$94.85M0.8912,266 shs2,026 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
+0.83%-4.19%-35.81%-16.46%-6.01%
AECOM stock logo
ACM
AECOM
+0.14%+1.60%-1.97%+5.92%+15.25%
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
-0.33%-0.50%-3.55%+1.19%-0.17%
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
-3.55%+4.14%+0.15%-21.53%-9.27%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
2.0545 of 5 stars
3.05.00.00.00.60.81.3
AECOM stock logo
ACM
AECOM
4.466 of 5 stars
3.55.00.81.73.21.71.3
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
2.00
Hold$4.00422.88% Upside
AECOM stock logo
ACM
AECOM
3.00
Buy$105.4312.49% Upside
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/AN/A
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
N/AN/AN/AN/A

Current Analyst Ratings

Latest SRL, MRM, ACM, and ACHL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
AECOM stock logo
ACM
AECOM
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$107.00 ➝ $116.00
4/19/2024
AECOM stock logo
ACM
AECOM
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$104.00 ➝ $105.00
4/5/2024
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
Chardan Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $6.00
4/5/2024
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral$8.00 ➝ $2.00
3/14/2024
AECOM stock logo
ACM
AECOM
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$106.00
2/13/2024
AECOM stock logo
ACM
AECOM
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$90.00 ➝ $100.00
2/7/2024
AECOM stock logo
ACM
AECOM
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$109.00
2/6/2024
AECOM stock logo
ACM
AECOM
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$100.00 ➝ $103.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/AN/AN/AN/A$3.49 per shareN/A
AECOM stock logo
ACM
AECOM
$14.38B0.89$5.00 per share18.73$17.18 per share5.46
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
$53.25M0.55$0.52 per share11.43($0.09) per share-66.22
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
$48.99M1.94$0.98 per share6.54$17.25 per share0.37

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
-$69.67M-$1.74N/AN/AN/AN/A-42.55%-37.54%5/8/2024 (Estimated)
AECOM stock logo
ACM
AECOM
$55.33M$0.45208.2718.741.400.42%21.45%4.80%5/6/2024 (Confirmed)
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
$1.15MN/A0.00N/AN/AN/AN/A5/29/2024 (Estimated)
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
-$18MN/A0.00N/AN/AN/AN/AN/A

Latest SRL, MRM, ACM, and ACHL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
AECOM stock logo
ACM
AECOM
$1.04N/A-$1.04N/AN/AN/A  
4/4/2024Q4 2023
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/A-$0.46-$0.46-$0.46N/AN/A
2/6/2024Q1 24
AECOM stock logo
ACM
AECOM
$0.92$1.05+$0.13$1.41N/A$3.90 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/AN/AN/AN/AN/A
AECOM stock logo
ACM
AECOM
$0.880.94%N/A195.56%2 Years
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/AN/AN/A
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
$0.172.66%N/AN/A1 Years

Latest SRL, MRM, ACM, and ACHL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/21/2024
AECOM stock logo
ACM
AECOM
quarterly$0.220.92%4/23/20244/24/20245/10/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
N/A
8.57
8.57
AECOM stock logo
ACM
AECOM
0.87
1.05
1.05
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/AN/AN/A
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
56.38%
AECOM stock logo
ACM
AECOM
85.41%
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
N/A
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
41.96%

Insider Ownership

CompanyInsider Ownership
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
5.38%
AECOM stock logo
ACM
AECOM
0.42%
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
40.24%
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
1.87%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Achilles Therapeutics plc stock logo
ACHL
Achilles Therapeutics
20439.88 million37.73 millionNot Optionable
AECOM stock logo
ACM
AECOM
52,000136.02 million135.45 millionOptionable
MEDIROM Healthcare Technologies Inc. stock logo
MRM
MEDIROM Healthcare Technologies
4344.88 million2.92 millionNot Optionable
Scully Royalty Ltd. stock logo
SRL
Scully Royalty
7114.82 million14.55 millionOptionable

SRL, MRM, ACM, and ACHL Headlines

SourceHeadline
Scully Royalty (NYSE:SRL) Stock Price Crosses Below Fifty Day Moving Average of $6.88Scully Royalty (NYSE:SRL) Stock Price Crosses Below Fifty Day Moving Average of $6.88
americanbankingnews.com - April 20 at 4:22 AM
Scully Royalty Ltd. (NYSE:SRL) Sees Significant Decrease in Short InterestScully Royalty Ltd. (NYSE:SRL) Sees Significant Decrease in Short Interest
marketbeat.com - April 12 at 4:32 PM
Roll Like Royalty in This 81 Corniche – and Go Bankrupt Real Quick, TooRoll Like Royalty in This '81 Corniche – and Go Bankrupt Real Quick, Too
autoevolution.com - April 9 at 8:41 PM
Scully Royalty Ltd. (NYSE:SRL) Sees Significant Decline in Short InterestScully Royalty Ltd. (NYSE:SRL) Sees Significant Decline in Short Interest
marketbeat.com - March 27 at 12:43 PM
Scully Royalty Ltd.Scully Royalty Ltd.
wsj.com - March 1 at 6:25 PM
Scully Royalty Stock (NYSE:SRL), Quotes and News SummaryScully Royalty Stock (NYSE:SRL), Quotes and News Summary
benzinga.com - February 23 at 1:51 PM
Lisa M. ScullyLisa M. Scully
health.usnews.com - February 9 at 7:50 PM
Scully Royalty Ltd. (SRL)Scully Royalty Ltd. (SRL)
finance.yahoo.com - January 30 at 4:35 PM
SRL Scully Royalty Ltd.SRL Scully Royalty Ltd.
seekingalpha.com - January 18 at 8:46 PM
Shareholders May Be More Conservative With Scully Royalty Ltd.s (NYSE:SRL) CEO Compensation For NowShareholders May Be More Conservative With Scully Royalty Ltd.'s (NYSE:SRL) CEO Compensation For Now
finance.yahoo.com - December 23 at 9:45 AM
Sean ScullySean Scully
artnet.com - December 21 at 11:39 PM
SRL Stock Earnings: Scully Royalty Reported Results for H1 2023SRL Stock Earnings: Scully Royalty Reported Results for H1 2023
investorplace.com - December 12 at 7:05 AM
SCULLY ROYALTY LTD. PUBLISHES RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023SCULLY ROYALTY LTD. PUBLISHES RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023
finance.yahoo.com - December 11 at 7:51 PM
Scully Royalty Ltd SRLScully Royalty Ltd SRL
morningstar.com - November 23 at 7:45 AM
Some Scully Royalty Ltd. (NYSE:SRL) Shareholders Look For Exit As Shares Take 30% PoundingSome Scully Royalty Ltd. (NYSE:SRL) Shareholders Look For Exit As Shares Take 30% Pounding
finance.yahoo.com - October 19 at 9:05 AM
SRL - Scully Royalty Ltd.SRL - Scully Royalty Ltd.
au.finance.yahoo.com - August 2 at 6:40 AM
London mayor: Paul Scully fails to make Conservative Party shortlistLondon mayor: Paul Scully fails to make Conservative Party shortlist
bbc.co.uk - July 3 at 7:18 PM
John ScullyJohn Scully
health.usnews.com - June 17 at 8:04 PM
Paul Scully will go to war on inner city councils who refuse to increase housing densityPaul Scully will go to war on inner city councils who refuse to increase housing density
dailytelegraph.com.au - June 15 at 7:56 PM
Paul Scully MP announces pitch to be Tory candidate for mayor of LondonPaul Scully MP announces pitch to be Tory candidate for mayor of London
aol.co.uk - June 9 at 7:08 PM
Despite currently being unprofitable, Scully Royalty (NYSE:SRL) has delivered a 44% return to shareholders over 5 yearsDespite currently being unprofitable, Scully Royalty (NYSE:SRL) has delivered a 44% return to shareholders over 5 years
finance.yahoo.com - June 8 at 10:43 AM
Fumihito, Kiko mingle with royalty during coronation visitFumihito, Kiko mingle with royalty during coronation visit
asahi.com - May 30 at 7:17 AM
Friday Is Your Last Chance To Buy Scully Royalty Before The Dividend PayoutFriday Is Your Last Chance To Buy Scully Royalty Before The Dividend Payout
msn.com - May 3 at 12:54 PM
Institutional investors own a significant stake of 40% in Scully Royalty Ltd. (NYSE:SRL)Institutional investors own a significant stake of 40% in Scully Royalty Ltd. (NYSE:SRL)
finance.yahoo.com - April 26 at 7:22 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Achilles Therapeutics logo

Achilles Therapeutics

NASDAQ:ACHL
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.
AECOM logo

AECOM

NYSE:ACM
AECOM, together with its subsidiaries, provides professional infrastructure consulting services worldwide. It operates in three segments: Americas, International, and AECOM Capital. The company offers planning, consulting, architectural and engineering design, construction and program management, and investment and development services to public and private clients. It is also involved in the investment and development of real estate projects. In addition, the company provides construction services, including building construction and energy, and infrastructure and industrial construction. It serves transportation, water, government, facilities, environmental, and energy sectors. The company was formerly known as AECOM Technology Corporation and changed its name to AECOM in January 2015. AECOM was incorporated in 1980 and is headquartered in Dallas, Texas.
MEDIROM Healthcare Technologies logo

MEDIROM Healthcare Technologies

NYSE:MRM
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Scully Royalty logo

Scully Royalty

NYSE:SRL
Scully Royalty Ltd. operates as an iron ore mining company in the Americas, Africa, Canada, Asia, and Europe. It operates through three segments: Royalty, Industrial, and Merchant Banking. The company holds royalty interest in the Scully iron ore mine located in the Province of Newfoundland and Labrador, Canada. It also engages in manufacturing, and medical supplies and services industries. In addition, the company offers merchant banking and financial services to small and medium sized enterprises; operates projects in resources and services; and holds two industrial real estate parks. Scully Royalty Ltd. was formerly known as MFC Bancorp Ltd. and changed its name to Scully Royalty Ltd. in June 2019. The company was incorporated in 2017 and is based in Shanghai, the People's Republic of China.